Exploring Novel Frontiers: Leveraging STAT3 Signaling for Advanced Cancer Therapeutics is a research paper published in Cancers (2024). On theSindex it has a DataRank of 0. It has been cited 21 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH/NCI
Grant: CA255960
NIH/NCI
Grant: CA223772
NIH/NCI
Grant: RP180712
NIH/NCI
Grant: K12 CA088084-21
National Institutes of Health
Grant: 5R01CA223772-03
Cytoplasmic cyclin E is an early event for progression to invasive breast cancer
National Institutes of Health
Grant: 5K12CA088084-02
CLINICAL ONCOLOGY RESEARCH CAREER DEVELOPMENT PROGRAM
National Institutes of Health
Grant: 5R01CA255960-03
Targeting STAT3 for the Treatment of CDK4/6 Inhibitor Resistant Advanced Estrogen Receptor Positive Breast Cancer Patients
FWCI
4.03
Citation Percentile
1.0%
Influential Citations
1
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals